Total Payments
$6,341
2024 Payments
$3,093
Companies
28
Transactions
279
Medicare Patients
2,428
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$6,135 (96.7%)
Education$206.17 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,135 | 276 | 96.7% |
| Education | $206.17 | 3 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $1,216 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $989.80 | 31 | $0 (2024) |
| Grifols USA, LLC | $766.39 | 34 | $0 (2024) |
| GENZYME CORPORATION | $569.17 | 31 | $0 (2024) |
| CSL Behring | $537.41 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $358.02 | 20 | $0 (2024) |
| Pharming Healthcare, Inc. | $254.18 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $226.93 | 8 | $0 (2024) |
| Optinose US, Inc. | $174.65 | 9 | $0 (2024) |
| PFIZER INC. | $162.45 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,093 | 146 | AstraZeneca Pharmaceuticals LP ($560.22) |
| 2023 | $1,588 | 71 | Grifols USA, LLC ($383.47) |
| 2022 | $761.61 | 28 | Regeneron Healthcare Solutions, Inc. ($280.00) |
| 2021 | $144.19 | 2 | Regeneron Healthcare Solutions, Inc. ($144.19) |
| 2020 | $135.36 | 7 | GlaxoSmithKline, LLC. ($72.03) |
| 2019 | $203.43 | 9 | ALK-Abello, Inc ($72.97) |
| 2018 | $266.28 | 11 | CSL Behring ($173.01) |
| 2017 | $148.89 | 5 | Intuitive Surgical, Inc. ($88.87) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: BIOLOGIC | ||||||
| 12/04/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Immunology | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: BIOLOGIC | ||||||
| 11/13/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Immunology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Immunology | ||||||
| 10/23/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Immunology | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/15/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: BIOLOGIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 444 | 6,268 | $206,842 | $120,646 |
| 2022 | 14 | 565 | 11,783 | $411,937 | $272,559 |
| 2021 | 13 | 692 | 16,843 | $561,063 | $384,398 |
| 2020 | 14 | 727 | 13,442 | $425,756 | $277,823 |
Total Patients
2,428
Total Services
48,336
Medicare Billing
$1.1M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 15 | 2,959 | $120,324 | $87,460 | 72.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 38 | 747 | $15,795 | $8,747 | 55.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 74 | $14,340 | $6,104 | 42.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 27 | 1,824 | $19,464 | $5,593 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $7,917 | $3,625 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 62 | $8,470 | $2,871 | 33.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 74 | 275 | $7,236 | $1,926 | 26.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 125 | $4,050 | $1,202 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,726 | $1,159 | 42.5% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 44 | 109 | $2,797 | $817.95 | 29.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 16 | 23 | $2,330 | $659.56 | 28.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 24 | 25 | $1,393 | $482.08 | 34.6% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 13 | 6,658 | $253,574 | $197,521 | 77.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 300 | $58,500 | $26,948 | 46.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 45 | 2,743 | $21,944 | $8,692 | 39.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 24 | 720 | $12,240 | $8,627 | 70.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $16,510 | $7,612 | 46.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 24 | 146 | $13,140 | $7,566 | 57.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 77 | $10,549 | $5,039 | 47.8% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 22 | 490 | $4,900 | $3,276 | 66.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 32 | 402 | $10,050 | $3,228 | 32.1% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 14 | 14 | $3,990 | $1,870 | 46.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 104 | $3,120 | $1,155 | 37.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 29 | 30 | $1,650 | $509.76 | 30.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 17 | 18 | $1,530 | $467.35 | 30.5% |
About Dr. Brian Reed, MD
Dr. Brian Reed, MD is a Allergy healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2012. The National Provider Identifier (NPI) number assigned to this provider is 1538432190.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Reed, MD has received a total of $6,341 in payments from pharmaceutical and medical device companies, with $3,093 received in 2024. These payments were reported across 279 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,135).
As a Medicare-enrolled provider, Reed has provided services to 2,428 Medicare beneficiaries, totaling 48,336 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy
- Location Pensacola, FL
- Active Since 02/13/2012
- Last Updated 12/01/2023
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1538432190
Products in Payments
- DUPIXENT (Biological) $1,861
- TEZSPIRE (Biological) $621.14
- Xembify (Biological) $493.93
- Haegarda (Biological) $299.01
- FASENRA (Biological) $288.83
- Prolastin-C Liquid (Biological) $272.46
- RUCONEST (Biological) $254.18
- Hizentra (Biological) $210.08
- TRELEGY ELLIPTA (Drug) $180.32
- Xhance (Drug) $174.65
- NUCALA (Biological) $162.82
- Xolair (Biological) $159.87
- PANZYGA (Biological) $138.61
- AIRSUPRA (Drug) $106.74
- FASENRA (Drug) $94.73
- Da Vinci Surgical System (Device) $88.87
- HYQVIA (Biological) $84.25
- TAKHZYRO (Biological) $82.17
- ORLADEYO (Drug) $80.80
- PRE-PEN (Drug) $72.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.